Chlamydia pneumoniae, IgG and IgM
Use
This test is intended for the qualitative detection and semi-quantitation of human serum IgM and IgG antibodies to Chlamydia pneumoniae. It aids in the diagnosis of community-acquired pneumonia caused by Chlamydia pneumoniae in individuals presenting with pneumonia.
Special Instructions
Not provided.
Limitations
Results of this test are labeled for investigational purposes only by the assay's manufacturer. The performance characteristics of this assay have not been established by the manufacturer. The result should not be used for the treatment or for diagnostic purposes without confirmation of the diagnosis by another medically established diagnostic product or procedure. The performance characteristics were determined by Labcorp. All results must be correlated with clinical history, epidemiological data and other clinical data. The performance of this assay has not been established for diagnosing non-pneumonia diseases associated with Chlamydia pneumoniae (e.g., bronchitis, sinusitis, otitis, coronary heart disease, asthma and multiple sclerosis). A negative result does not rule out a present acute infection. A positive result does not always indicate a present acute infection as antibodies can persist in some patients for several months or more.
Methodology
Immunoassay
Biomarkers
LOINC Codes
- 77166-7
- 6913-8
- 6914-6
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Refrigerate. Per the package insert: Samples are stable at room temperature for eight hours. After eight hours, samples should be refrigerated at 2° to 8°C for up to 48 hours. After 48 hours, freeze samples at -20°C or colder.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 8 hours |
| Refrigerated | 48 hours |
